Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...

Scientists have uncovered the first evidence of Alzheimer's disease transmission in living individuals, marking a significant ...

Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results ...

In part three of five articles by Siren Interactive, Eileen O’Brien discusses how important patient registries are for the acceleration of orphan drugs and the awareness of rare diseases ...

New Inflammatory Bowel Disease Testing Protocol Could Speed Up Diagnosis Apr. 16, 2024 — Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that ...

In the assessment of 12-month price targets, analysts unveil insights for Sangamo Therapeutics, presenting an average target ...

working with some of the most dedicated ambassadors for rare disease, from researchers to patient advocates to patients and families. What motivates me to dedicate my career to rare diseases and ...